BG105011A - Composition containing paroxetine - Google Patents

Composition containing paroxetine

Info

Publication number
BG105011A
BG105011A BG105011A BG10501100A BG105011A BG 105011 A BG105011 A BG 105011A BG 105011 A BG105011 A BG 105011A BG 10501100 A BG10501100 A BG 10501100A BG 105011 A BG105011 A BG 105011A
Authority
BG
Bulgaria
Prior art keywords
composition containing
containing paroxetine
hemihydrate
paroxetine
formulated
Prior art date
Application number
BG105011A
Other languages
Bulgarian (bg)
Inventor
David Elder
Graham LEONARD
Original Assignee
Smithkline Beecham Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Plc filed Critical Smithkline Beecham Plc
Publication of BG105011A publication Critical patent/BG105011A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/4525—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with oxygen as a ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/485—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Neurology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Inorganic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

Paroxetine hydrochloride, in a form other than hemihydrate, which is formulated into capsules under conditions such there is no detectable conversion to hemihydrate during the manufacturing process. 8 claims
BG105011A 1998-05-13 2000-11-30 Composition containing paroxetine BG105011A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9810180.1A GB9810180D0 (en) 1998-05-13 1998-05-13 Novel formulation
PCT/GB1999/001522 WO1999058116A2 (en) 1998-05-13 1999-05-13 Novel formulation containing paroxetine

Publications (1)

Publication Number Publication Date
BG105011A true BG105011A (en) 2001-07-31

Family

ID=10831926

Family Applications (1)

Application Number Title Priority Date Filing Date
BG105011A BG105011A (en) 1998-05-13 2000-11-30 Composition containing paroxetine

Country Status (20)

Country Link
EP (1) EP1077685A2 (en)
JP (1) JP2002514593A (en)
KR (1) KR20010043545A (en)
CN (1) CN1309557A (en)
AP (1) AP2000001985A0 (en)
AU (1) AU3941099A (en)
BG (1) BG105011A (en)
BR (1) BR9910402A (en)
CA (1) CA2331849A1 (en)
EA (1) EA200001173A1 (en)
GB (1) GB9810180D0 (en)
HU (1) HUP0101931A3 (en)
ID (1) ID27018A (en)
IL (1) IL139596A0 (en)
NO (1) NO20005681L (en)
PL (1) PL344872A1 (en)
SK (1) SK16972000A3 (en)
TR (1) TR200003351T2 (en)
WO (1) WO1999058116A2 (en)
ZA (1) ZA200006465B (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1161241B1 (en) * 1999-03-12 2005-12-07 Aesica Pharmaceuticals Ltd. Stable pharmaceutical application form for paroxetin anhydrate
HU226912B1 (en) * 2000-04-07 2010-03-01 Richter Gedeon Nyrt New paroxetin salt and medicament containing it
WO2013145750A1 (en) * 2012-03-29 2013-10-03 杏林製薬株式会社 Capsule pharmaceutical preparation
DE102013207447A1 (en) 2013-04-24 2014-10-30 Evonik Degussa Gmbh Process and apparatus for the preparation of octachlorotrisilane
CN103520131B (en) * 2013-10-12 2019-05-14 浙江华海药业股份有限公司 The preparation method of paroxetine hydrochloride semihydrate capsule
CN103961333B (en) * 2014-05-07 2020-02-21 浙江华海药业股份有限公司 Paroxetine mesylate capsule and preparation method thereof

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2216934A1 (en) * 1995-04-03 1996-10-10 Abbott Laboratories Homogeneous mixtures of low temperature-melting drugs and additives for controlled release
GB9724544D0 (en) * 1997-11-21 1998-01-21 Smithkline Beecham Plc Novel Formulation

Also Published As

Publication number Publication date
PL344872A1 (en) 2001-11-19
EP1077685A2 (en) 2001-02-28
KR20010043545A (en) 2001-05-25
GB9810180D0 (en) 1998-07-08
BR9910402A (en) 2001-01-09
NO20005681L (en) 2000-12-01
WO1999058116A2 (en) 1999-11-18
CN1309557A (en) 2001-08-22
AU3941099A (en) 1999-11-29
HUP0101931A3 (en) 2002-10-28
AP2000001985A0 (en) 2000-12-31
HUP0101931A2 (en) 2002-04-29
IL139596A0 (en) 2002-02-10
WO1999058116A3 (en) 2000-02-17
TR200003351T2 (en) 2001-03-21
NO20005681D0 (en) 2000-11-10
EA200001173A1 (en) 2001-04-23
SK16972000A3 (en) 2001-06-11
ID27018A (en) 2001-02-22
JP2002514593A (en) 2002-05-21
ZA200006465B (en) 2001-11-09
CA2331849A1 (en) 1999-11-18

Similar Documents

Publication Publication Date Title
EP0655459A3 (en) Method for introducing a 1,2 double bond into 4-azasteroids, and crystalline phroscor(R) and pharmaceutical compositions thereof.
PL319384A1 (en) Steroic compositions from soap mass
BG102259A (en) Compostions with controlled paroxetine release
PL345215A1 (en) Novel form of irbesartan, methods for obtaining said form and pharmaceutical compositions containing same
HK1042698B (en) New diphenylurea compounds, a process for their preparation and pharmaceutical compositions containing them
MX9700273A (en) Substituted benzamidines, their production and their use as medicaments.
BG105197A (en) Polymorph form of a medicament
YU12000A (en) Substituted 1,2,3,4,,5,6,-hexahydro-2,6-methano-3- benzazocine-10-oles, method for the production and use thereof as medicaments
BG105011A (en) Composition containing paroxetine
GB0029774D0 (en) Clay composition
ZA99477B (en) Process for the preparation of (-)CIS-3-Hydroxy-1-Methyl-4-(2,4,6-Trimethoxyphenyl)Piperidine.
WO1999037291A3 (en) Utilization of substituted sulfonamides as antiviral agents and novel substances
PL352104A1 (en) Oral composition containing perlite
HUP0202379A3 (en) New compounds, process for producing them and pharmaceutical compositions containing them
SI1206452T1 (en) Novel method for preparing benzoperhydroisoindole compounds
HUP0000308A2 (en) New cyano-indole serotonin-reuptake inhibitor compounds, a process for their preparation and pharmaceutical compositions containing them
BG105010A (en) Medicamentous form containing paroxetine
EP1044394A4 (en) Process for preparing a radiation-sensitive composition
HK1029025A1 (en) Compressed chloramine-t tablets and method for the production thereof
HK1051845A1 (en) Substituted 1 and 2 naphthol mannich bases
IL148161A0 (en) Process for the preparation of 2-cyanopyridines
HUP0200187A3 (en) A process for the preparation of 1,4,7,10-tetraazacyclododecane
CA2331758A1 (en) Method for the stereochemically controlled production of isomerically pure highly substituted azacyclic compounds
YU71400A (en) Improved method for preparing pharmaceutically valuable norbenzomorphane derivatives
WO1999040078A3 (en) Process for the preparation of sotolon